L754-0625 Screening compound: N~1~-{[4-(3-methylbenzoyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl]methyl}-N~1~-(4-methylphenyl)acetamide

L754-0625 Screening compound: N~1~-{[4-(3-methylbenzoyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl]methyl}-N~1~-(4-methylphenyl)acetamide
L754-0625 Screening compound: N~1~-{[4-(3-methylbenzoyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl]methyl}-N~1~-(4-methylphenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L754-0625
N~1~-{[4-(3-methylbenzoyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl]methyl}-N~1~-(4-methylphenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L754-0625

Molecular Formula

C27H28N2O3 (C27 H28 N2 O3)

Compound Name

N~1~-{[4-(3-methylbenzoyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl]methyl}-N~1~-(4-methylphenyl)acetamide

IUPAC name

n/a

SMILES

CC(N(Cc(cc1)cc(C2)c1OCCN2C(c1cc(C)ccc1)=O)c1ccc(C)cc1)=O

InChI

InChI=1S/C27H28N2O3/c1-19-7-10-25(11-8-19)29(21(3)30)17-22-9-12-26-24(16-22)18-28(13-14-32-26)27(31)23-6-4-5-20(2)15-23/h4-12,15-16H,13-14,17-18H2,1-3H3

InChI Key

CEQLILHGJOVTPK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27473825

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.560

Distribution Coefficient, logD

4.560

Water Solubility, LogSw

-4.41

Polar Surface Area

40.921

Acid Dissociation Constant (pKa)

22.47

Base Dissociation Constant (pKb)

-1.22

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.90

L754-0625 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L754-0625 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L754-0625?
Check Price and Availability of L754-0625, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L754-0625 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L754-0625
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L754-0625
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L754-0625 available by request